| Source: |
| Type: protein |
| c-FLIP (cellular FLICE-like inhibitory protein) also know as FLIP - is a protein that plays a crucial role in the regulation of apoptosis, or programmed cell death. It is a key regulator of the extrinsic pathway of apoptosis, which is mediated by death receptors such as Fas and TNF-R1. c-FLIP is a pseudokinase that can inhibit the activation of caspase-8, a key enzyme in the extrinsic pathway of apoptosis. By inhibiting caspase-8 activation, c-FLIP can prevent the initiation of the apoptotic cascade and promote cell survival. In cancer, c-FLIP is often overexpressed, which can contribute to the development and progression of the disease. CFLAR (CASP8 and FADD Like Apoptosis Regulator; c-FLIP) — Apoptosis-regulatory protein structurally related to caspase-8 but lacking caspase protease activity. CFLAR/c-FLIP is recruited to the death-inducing signaling complex (DISC), where it regulates activation of caspase-8 and signaling downstream of death receptors such as FAS and TRAIL receptors. Typical modulation in cancer: ↑ CFLAR/c-FLIP is generally tumor-promoting because it suppresses death-receptor-mediated apoptosis, supports cancer-cell survival, and can contribute to resistance to TRAIL, FAS signaling, chemotherapy, and other anticancer treatments. CFLAR ↓ or inhibition generally sensitizes tumor cells to extrinsic apoptosis. Typical modulation in Alzheimer’s disease: No well-established Alzheimer’s disease-specific direction. CFLAR may influence inflammatory and apoptosis-related signaling, but it is not currently a core AD target. Typical mechanistic relationship: CFLAR/c-FLIP ↑ → caspase-8 activation ↓ → extrinsic apoptosis ↓; CFLAR/c-FLIP ↓ → caspase-8 activation ↑ → apoptosis ↑. |
| 1524- | Ba, | Baicalein Induces Caspase‐dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells |
| - | in-vitro, | Lung, | A549 |
| 2476- | Ba, | Baicalein Induces Caspase-dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells |
| - | in-vitro, | Lung, | A549 |
| 5179- | BBR, | Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy |
| - | Review, | Var, | NA |
| 6672- | Deg, | Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice |
| - | vitro+vivo, | CRC, | COLO205 | - | in-vitro, | CRC, | HCT116 |
| - | in-vitro, | Var, | NA |
| 5148- | GamB, | Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics |
| - | Review, | Var, | NA |
| 823- | GAR, | Garcinol Potentiates TRAIL-Induced Apoptosis through Modulation of Death Receptors and Antiapoptotic Proteins |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 | - | in-vitro, | CRC, | HCT116 |
| 794- | GAR, | Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression |
| - | in-vitro, | RCC, | NA | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | NA |
| 795- | GAR, | Garcinol—A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug |
| - | Review, | Var, | NA |
| 2884- | HNK, | Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 2868- | HNK, | Honokiol: A review of its pharmacological potential and therapeutic insights |
| - | Review, | Var, | NA | - | Review, | Sepsis, | NA |
| 2894- | HNK, | Pharmacological features, health benefits and clinical implications of honokiol |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 8152- | lamb, | TRAIL/rTRAIL, | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4 |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | Lung, | H1299 |
| 8237- | LCA, | Role of Licochalcone A in Potential Pharmacological Therapy: A Review |
| - | Review, | Var, | NA |
| 8231- | LCA, | Maintenance of the Expression of c-FLIPL by Hsp70 to Resist Licochalcone A-Induced Anti-Colorectal Cancer Effect through ERK-Mediated Autophagy Induction |
| - | in-vitro, | CRC, | NA |
| 8717- | MeJa, | Methyl jasmonate induces apoptosis and pro-apoptotic autophagy via the ROS pathway in human non-small cell lung cancer |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | Lung, | Calu-1 | - | in-vitro, | Lung, | H157 | - | in-vitro, | Lung, | H1792 |
| 8859- | MOR, | Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1 |
| - | in-vitro, | Melanoma, | U266 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | SCC, | SCC4 | - | in-vitro, | BC, | MCF-10AT |
| 8967- | mushLions, | Recent developments in mushrooms as anti-cancer therapeutics: a review |
| - | Review, | Var, | NA |
| 8963- | PatchO, | The Effect of Patchouli Oil (Pogostemon cablin) on Apoptosis through NF-κB Inhibition in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 3354- | QC, | Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine |
| - | Review, | Var, | NA |
| 3368- | QC, | The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update |
| - | Review, | Var, | NA |
| 910- | QC, | The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism |
| - | Review, | Var, | NA |
| 916- | QC, | Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells |
| - | Review, | Ovarian, | NA |
| 914- | QC, | Quercetin and Cancer Chemoprevention |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:885 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid